These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34155426)

  • 21. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.
    Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA
    Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
    Goddanti N; Reddy YM; Kumar MK; Rajesh M; Reddy LS
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3498-3504. PubMed ID: 34804904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by
    Erami M; Mirhendi H; Momen-Heravi M; Hezaveh SJH; Ahsaniarani AH; Sabet SS; Aboutalebian S
    Front Cell Infect Microbiol; 2022; 12():898477. PubMed ID: 36310874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
    Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
    An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: Demographics and risk factors in a single-centre consecutive cohort of 200 inpatients.
    Singh A; Sikka K; Goel G; Kanodia A; Chandran A; Konkimalla A; Panda S; Garg RK; Xess I; Tandon N; Thakar A
    Natl Med J India; 2022; 35(3):132-137. PubMed ID: 36461870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis.
    Sedaghattalab M; Bagheri T; Doustimotlagh AH
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19-associated mucormycosis of head-and-neck region: A systematic review.
    Kamat M; Datar U; Byakodi S; Kamat S; Vimal Kumar V
    J Clin Transl Res; 2022 Feb; 8(1):31-42. PubMed ID: 35187287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
    Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
    J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
    Mehfooz S; Mehrotra N; Usmani T; Raj V
    Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
    Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
    Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist's Perspective.
    Bilgic A; Kodjikian L; Sudhalkar A; Dwivedi S; Vasavada V; Shah A; Dziadzko M; Mathis T
    J Fungi (Basel); 2022 Mar; 8(3):. PubMed ID: 35330273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India.
    Chakrabarti SS; Kaur U; Aggarwal SK; Kanakan A; Saini A; Agrawal BK; Jin K; Chakrabarti S
    Aging Dis; 2022 Feb; 13(1):24-28. PubMed ID: 35111359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value.
    Anand C B; Senthilkumar S; P N; Ibrahim C M; Afroze M KH; M R
    Cureus; 2022 Apr; 14(4):e24013. PubMed ID: 35547446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
    Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
    Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Et tu Mucor?
    Khatri A; Prasai G; Pandey M; Kharel M; Bohara D; Panthi M
    Nepal J Ophthalmol; 2021 Jul; 13(24):177-185. PubMed ID: 35996792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study.
    Kordjazi M; Bazgir N; Eftekharian K; Farajpour M; Dilmaghani NA
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):145S-152S. PubMed ID: 36583239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.